Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSECN.L Regulatory News (SECN)

  • There is currently no data for SECN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

22 Feb 2022 07:00

RNS Number : 3406C
SEC Newgate S.p.A.
22 February 2022
 

For immediate release

22 February 2022

 

SEC Newgate S.p.A. ("SEC Newgate" or the "Company")

 

Transaction in own shares

 

SEC Newgate (AIM:SECN), the insight-driven global strategic communications group that works at the nexus of business, politics, communities, markets and media, announces that it yesterday made the following purchases of Ordinary Shares pursuant to the Buy-back announced on 17 February 2022.

Date of purchases: 21 February 2022

Number of Ordinary Shares purchased: 418,576

Highest price paid per Ordinary Share: 111.32p

Lowest price paid per Ordinary Share: 111.32p

Volume weighted average price: 111.32p

The Company will hold the above Ordinary Shares in treasury.

Following the repurchase of the Ordinary Shares set out above, the Company's issued share capital consists of 23,461,493 Ordinary Shares (excluding treasury shares), and the Company will hold 1,249,429 Ordinary Shares in treasury. Therefore, the total voting rights in the Company will be 23,461,493. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The Company will make further announcements in due course following the completion of any further purchases pursuant to the Buy-back.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the detailed breakdown of individual trades made by Arden Partners on behalf of the Company as part of the share buyback programme is set out below.

Transaction date and time

Number of shares purchased

Transaction price (pence per share)

Trading venue

21/02/2022, 09:13

43,670

111.32

AIMX

21/02/2022, 09:35

275,000

111.32

AIMX

21/02/2022, 10:19

95

111.32

AIMX

21/02/2022, 12:17

15,400

111.32

AIMX

21/02/2022, 12:41

23,300

111.32

AIMX

21/02/2022, 13:43

47

111.32

AIMX

21/02/2022, 13:47

514

111.32

AIMX

21/02/2022, 14:16

53,612

111.32

AIMX

21/02/2022, 14:38

4,000

111.32

AIMX

21/02/2022, 14:43

2,825

111.32

AIMX

21/02/2022, 14:46

113

111.32

AIMX

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

Media Enquiries

Fiorenzo Tagliabue (Group CEO)

Tel: +39 335 6008858

tagliabue@secrp.com

Emma Kane (Deputy Group CEO, 

CEO SEC Newgate UK) 

Tel: +44 (0) 7876 338339

emma.kane@secnewgate.co.uk

Sergio Penna (Group CFO)

penna@secrp.com

 

Arden Partners (Nominated Adviser and Broker)

 

Richard Johnson, Ben Christie 

Tel: +44 (0) 20 7614 5900

Notes to Editors

SEC Newgate's focus is on achieving positive outcomes through communications, advocacy and research, helping clients clearly demonstrate their purpose, value, and impact locally, nationally and internationally. Further information is available at the Group's website: www.secnewgate.com Further information on SEC Newgate UK is available at: www.secnewgate.co.uk
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSESFWFEESELE
Date   Source Headline
3rd Mar 20225:30 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSTransaction in Own Shares
2nd Mar 20227:00 amRNSTransaction in Own Shares
1st Mar 20227:00 amRNSTransaction in Own Shares
28th Feb 20225:30 pmRNSSec Newgate SPA
28th Feb 20227:00 amRNSTransaction in Own Shares
25th Feb 20221:44 pmRNSHolding(s) in Company
25th Feb 20227:52 amRNSTransaction in Own Shares
24th Feb 20227:00 amRNSTransaction in Own Shares
23rd Feb 20227:00 amRNSTransaction in Own Shares
22nd Feb 20227:00 amRNSHolding(s) in Company
22nd Feb 20227:00 amRNSTransaction in Own Shares
21st Feb 20229:30 amRNSTransaction in Own Shares
18th Feb 20227:30 amRNSTransaction in Own Shares
17th Feb 20227:00 amRNSCommencement of Buy-back
10th Feb 20221:00 pmRNSResult of General Meeting
10th Feb 20227:00 amRNSUpdate re Framework and Contribution Agreement
25th Jan 20227:00 amRNSNotice of General Meeting
19th Jan 202211:28 amRNSProposed AIM trading cancellation and financing
11th Nov 20217:00 amRNSTrading Update
26th Oct 20217:00 amRNSInaugural Global Thought Leadership Report
1st Sep 20217:01 amRNSNewington Vendor Consideration
1st Sep 20217:00 amRNSInterim Results
29th Jul 20217:00 amRNSAcquisition
28th Jun 20217:00 amRNSNew London Offices
10th Jun 20217:00 amRNSAnnual Report
8th Jun 20211:23 pmRNSUpdate re Corporate Nominee Facility
8th Jun 20211:12 pmRNSResult of AGM
28th May 20219:45 amRNSHolding(s) in Company
21st May 20218:14 amRNSIssue of Equity
21st May 20217:00 amRNSAudited Full Year Results
6th May 20217:00 amRNSYear End Trading Update and Notice of Results
22nd Mar 20217:00 amRNSExpansion in Central Eastern Europe
11th Mar 202112:33 pmRNSInvestor Presentation
24th Feb 20217:00 amRNSSEC Newgate UK wins prestigious industry award
2nd Feb 20217:01 amRNSBoard Changes
2nd Feb 20217:00 amRNSTrading Update
29th Jan 20217:00 amRNSDirector Dealing
26th Jan 20219:50 amRNSDirector Dealing
26th Jan 20219:00 amRNSEquity Research Initiation
19th Jan 202110:04 amRNSDirector/PDMR Shareholding
18th Jan 20217:00 amRNSMerger and Rebranding of UK Agencies

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.